Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 14, Issue 21, pp. 7138-7142
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted June 12, 2008
- Received January 15, 2008
- Revision received June 10, 2008
- Published first November 3, 2008.
Copyright & Usage
American Association for Cancer Research
Author Information
- Thehang H. Luu1,
- Robert J. Morgan1,
- Lucille Leong1,
- Dean Lim1,
- Mark McNamara1,
- Jana Portnow1,
- Paul Frankel2,
- David D. Smith2,
- James H. Doroshow1,
- David R. Gandara3,
- Ana Aparicio4,
- George Somlo1 and
- Carol Wong5
- Authors' Affiliations:1Division of Medical Oncology and Therapeutics Research and 2Department of Biostatistics, City of Hope Comprehensive Cancer Duarte, California; 3University of California, Davis Cancer Center, Sacramento, California; 4University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California; and 5Division of Diagnostic Radiology, City of Hope, Duarte, California
- Requests for reprints:
George Somlo, Division of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010. Phone: 626-359-8111; Fax: 626-301-8898; E-mail: gsomlo{at}coh.org.
November 2008
Volume 14, Issue 21
Volume 14, Issue 21
A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study
Jump to section
Advertisement